體學化驗服務全球市場規模、佔有率、趨勢和成長分析報告（2026-2034）

全球體學化驗服務市場預計將從2025年的1,035.2億美元成長至2034年的3,417.4億美元，2026年至2034年的複合年成長率（CAGR）為14.19%。全球體學化驗服務市場的擴張主要得益於基因組學、蛋白質組學和代謝體學研究需求的不斷成長。這些服務為個人化醫療、藥物研發和疾病診斷等領域的前沿研究提供了支持。生命科學研究投入的增加以及慢性病盛行率的上升是推動市場成長的關鍵因素。研究機構和製藥公司正擴大將體學服務外包給專業實驗室。

關鍵成長要素包括定序技術和生物資訊學工具的技術進步。基因測序成本的降低使得體學研究更容易進行。精準醫療和標靶治療日益成長的需求也推動了對全面體學分析的需求。此外，政府資助和合作研究計畫正在加速全球體學研究的擴展。

展望未來，由於多組體學方法的持續創新，市場預計將迎來顯著成長。人工智慧（AI）與巨量資料分析的融合將提升研究效率與洞察力。新興經濟體生物技術和製藥業的擴張將創造新的服務機會。隨著個人化醫療日益重要，體學檢測服務將在塑造未來醫學研究和治療發展中發揮關鍵作用。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為特定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別未來預期趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長地區和區域趨勢，以更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球體學化驗服務市場：依服務類型分類

• 市場分析、洞察與預測
• 基因組學
• 蛋白質體學
• 轉錄組學
• 代謝體學
• 表觀遺傳學

第5章 全球體學化驗服務市場：依最終用途分類

• 市場分析、洞察與預測
• 硬體設備（設備、套件、晶片）
• 檢測/實驗室（服務）
• 分析/解釋（個人化和解釋）

第6章 全球體學化驗服務市場：依產品分類

• 市場分析、洞察與預測
• 一次性服務
• 重複
• 連續的

第7章 全球體學化驗服務市場：依服務頻率分類

• 市場分析、洞察與預測
• 醫院
• 研究機構
• 診斷實驗室

第8章 全球體學化驗服務市場：依業務類型分類

• 市場分析、洞察與預測
• 癌症
• 藥品（處方藥、非處方藥）
• 生殖
• 其他基因檢測
• 法醫學
• 人口普查
• 護膚
• 營養
• 維生素和補充劑
• 家譜
• 其他類別

第9章 全球體學化驗服務市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 中國
  • 日本
  • 韓國
  • 印度
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Eurofins Scientific
  • QIAGEN
  • Thermo Fisher Scientific
  • Labcorp
  • Charles River Laboratories
  • Azenta
  • Discovery Life Sciences
  • WuXi AppTec
  • BGI
  • Novogene
  • Fulgent Genetics
  • NeoGenomics
  • Genewiz
  • MedGenome
  • Macrogen
  • CD Genomics
  • Creative Biolabs
  • Integrated DNA Technologies
  • Brooks Life Sciences
  • Personalis

The global omics lab services market size is expected to reach USD 341.74 Billion in 2034 from USD 103.52 Billion in 2025, growing at a CAGR of 14.19% during 2026-2034.The Global Omics Lab Services Market is expanding due to the increasing demand for genomics, proteomics, and metabolomics research. These services support advanced studies in personalized medicine, drug discovery, and disease diagnostics. Rising investments in life sciences research and the growing prevalence of chronic diseases are key factors driving market growth. Research institutions and pharmaceutical companies are increasingly outsourcing omics services to specialized laboratories.

Major growth drivers include technological advancements in sequencing technologies and bioinformatics tools. The decreasing cost of genomic sequencing has made omics research more accessible. Growing interest in precision medicine and targeted therapies is also fueling demand for comprehensive omics analysis. Additionally, government funding and collaborative research projects are encouraging the expansion of omics-based studies worldwide.

Looking forward, the market is expected to witness significant growth due to continuous innovation in multi-omics approaches. Integration of artificial intelligence and big data analytics will improve research efficiency and insights. Expansion of biotechnology and pharmaceutical industries in emerging economies will create new service opportunities. As personalized healthcare becomes more prominent, omics lab services will play a crucial role in shaping the future of medical research and treatment development.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Services

• Genomics
• Proteomics
• Transcriptomic
• Metabolomics
• Epigenetics

By End-Use

• Hardware Equipment (Instrument, Kits, Chips)
• Testing / Lab (Services)
• Analytics / Interpretation (Personalization and Interpretation)

By Product

• One-off
• Repeat
• Continuous

By Frequency of Service

• Hospitals
• Research Institutes
• Diagnostic Labs

By Business

• Cancer
• Pharmaco (Prescription, Non-Prescription)
• Reproductive
• Other Genetic Tests
• Forensics
• Population Studies
• Skincare
• Nutrition
• Vitamins and Supplements
• Genealogy
• Other Categories

COMPANIES PROFILED

• Eurofins Scientific, QIAGEN, Thermo Fisher Scientific, Labcorp, Charles River Laboratories, Azenta, Discovery Life Sciences, WuXi AppTec, BGI, Novogene, Fulgent Genetics, NeoGenomics, Genewiz, MedGenome, Macrogen, CD Genomics, Creative Biolabs, Integrated DNA Technologies, Brooks Life Sciences, Personalis

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL OMICS LAB SERVICES MARKET: BY SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Services
• 4.2. Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Proteomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Transcriptomic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Metabolomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Epigenetics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL OMICS LAB SERVICES MARKET: BY END-USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-use
• 5.2. Hardware Equipment (Instrument, Kits, Chips) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Testing / Lab (Services) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Analytics / Interpretation (Personalization and Interpretation) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL OMICS LAB SERVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Product
• 6.2. One-off Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Repeat Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Continuous Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL OMICS LAB SERVICES MARKET: BY FREQUENCY OF SERVICE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Frequency Of Service
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Diagnostic Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL OMICS LAB SERVICES MARKET: BY BUSINESS 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Business
• 8.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Pharmaco (Prescription, Non-Prescription) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Reproductive Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Other Genetic Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Forensics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.7. Population Studies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.8. Skincare Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.9. Nutrition Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.10. Vitamins and Supplements Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.11. Genealogy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.12. Other Categories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL OMICS LAB SERVICES MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Services
  • 9.2.2 By End-use
  • 9.2.3 By Product
  • 9.2.4 By Frequency Of Service
  • 9.2.5 By Business
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Services
  • 9.3.2 By End-use
  • 9.3.3 By Product
  • 9.3.4 By Frequency Of Service
  • 9.3.5 By Business
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Spain
  • 9.3.11 Russia
  • 9.3.12 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Services
  • 9.4.2 By End-use
  • 9.4.3 By Product
  • 9.4.4 By Frequency Of Service
  • 9.4.5 By Business
  • 9.4.6 China
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 India
  • 9.4.10 Australia
  • 9.4.11 South East Asia
  • 9.4.12 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Services
  • 9.5.2 By End-use
  • 9.5.3 By Product
  • 9.5.4 By Frequency Of Service
  • 9.5.5 By Business
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Services
  • 9.6.2 By End-use
  • 9.6.3 By Product
  • 9.6.4 By Frequency Of Service
  • 9.6.5 By Business
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL OMICS LAB SERVICES INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Eurofins Scientific
  • 11.2.2 QIAGEN
  • 11.2.3 Thermo Fisher Scientific
  • 11.2.4 Labcorp
  • 11.2.5 Charles River Laboratories
  • 11.2.6 Azenta
  • 11.2.7 Discovery Life Sciences
  • 11.2.8 WuXi AppTec
  • 11.2.9 BGI
  • 11.2.10 Novogene
  • 11.2.11 Fulgent Genetics
  • 11.2.12 NeoGenomics
  • 11.2.13 Genewiz
  • 11.2.14 MedGenome
  • 11.2.15 Macrogen
  • 11.2.16 CD Genomics
  • 11.2.17 Creative Biolabs
  • 11.2.18 Integrated DNA Technologies
  • 11.2.19 Brooks Life Sciences
  • 11.2.20 Personalis